SEC 13F Intelligence

Waddell & Reed Financial Inc / DC4

Waddell & Reed Financial Inc’s Dexcom Inc Position

Does Waddell & Reed Financial Inc own Dexcom Inc (DC4)? Yes — 880.2K shares worth $316M (+0.65% of its 13F portfolio) as of Q1 2021, up from 762.2K shares the prior filed quarter.

Position Value
$316M
Q1 2021
Shares
880.2K
% of Portfolio
+0.65%
Quarters Held
10
currently held

Position History DC4

Reported value by quarter
Q4 ’18: $123MQ4 ’18Q1 ’19: $124MQ2 ’19: $158MQ2 ’19Q3 ’19: $151MQ4 ’19: $172MQ4 ’19Q1 ’20: $190MQ2 ’20: $256MQ2 ’20Q3 ’20: $260MQ4 ’20: $282MQ4 ’20Q1 ’21: $316Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021880.2K$316M+0.65%
Q4 2020762.2K$282M+0.59%
Q3 2020629.8K$260M+0.62%
Q2 2020630.7K$256M+0.66%
Q1 2020705.4K$190M+0.62%
Q4 2019785.9K$172M+0.43%
Q3 20191.02M$151M+0.39%
Q2 20191.06M$158M+0.39%
Q1 20191.04M$124M+0.31%
Q4 20181.03M$123M+0.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Waddell & Reed Financial Inc’s full portfolio or all institutional holders of DC4.